StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.00+0.08 (+4.17%)

Close on Nov 17, 2026Market cap $90.49MP/E –Yield –

Genelux total assets

Total assets on the balance sheet at the end of each period.

Genelux's total assets was $26.21M at Jun 30, 2026. For fiscal 2025 it was $19.03M, down 45.2% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$19.03M-45.2%
FY2024Dec 31, 2024$34.72M+24.5%
FY2023Dec 31, 2023$27.89M+404.3%
FY2022Dec 31, 2022$5.53M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$26.21M-18.7%
Q1 FY2026Mar 31, 2026$32.37M-17.0%
Q4 FY2025Dec 31, 2025$19.03M-45.2%
Q3 FY2025Sep 30, 2025$24.99M-38.0%
Q2 FY2025Jun 30, 2025$32.25M-28.6%
Q1 FY2025Mar 31, 2025$38.99M+58.0%
Q4 FY2024Dec 31, 2024$34.72M+24.5%
Q3 FY2024Sep 30, 2024$40.27M+18.2%
Q2 FY2024Jun 30, 2024$45.18M+44.1%
Q1 FY2024Mar 31, 2024$24.68M+68.8%
Q4 FY2023Dec 31, 2023$27.89M+404.3%
Q3 FY2023Sep 30, 2023$34.07M–
Q2 FY2023Jun 30, 2023$31.36M–
Q1 FY2023Mar 31, 2023$14.62M–
Q4 FY2022Dec 31, 2022$5.53M–

More Genelux figures

See a number that looks wrong?